Areas of Focus
- Mechanisms and drug targets of cardiovascular diseases such as atherosclerosis and diabetic vascular injury
- Biomarkers and drug target validation for inflammation-related diseases such as atherosclerosis, adenomyosis, and tumors based on multi-omics
- Validation and mechanism research of traditional Chinese medicine monomers or compounds in disease treatment
Work Experience
- 2005/9 - Present - Nanjing University, School of Medicine - Lecturer, Associate Professor
Academic Background & Achievements
- 2002.9 – 2005.6 Ph.D. in Pharmacology: China Pharmaceutical University
- 2009.4 – 2011.12 Postdoctoral in Biology: Nanjing University School of Life Sciences
- 2015.10 – 2016.10 Postdoctoral in Biochemistry and Molecular Pharmacology: Harvard Medical School